| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Rental Companies Have Record Year |
|
Just Other Articles - Rental Companies Have Record Year
2005 proved to be a very good year for the rental industry. Several
compa According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nies showed record earnings and revenues last year. Caterpillar,
H&E, Ing ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rsoll-Rand, and JLG were among the leaders in earnings. Caterpillar, Peori lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a, IL, had record profits and revenues in the third
quarter. With revenue here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of $8.98 billion and profit of $667 million both
numbers were up dramatic d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lly from the 2004 year. Caterpillar attributed
the growth to strong globa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc l demand and improved pricing. H&E Equipment out of Baton Rouge, LA had a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ery strong third quarter
as well. Their gross profit rose to $13.4 millio nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n, an increase of 40.1
percent from the year before. They also had a reve and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ue increase of 22.7
percent to $27.5 million that quarter. Ingersoll-Rand ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Annadale, NJ showed an increase of 10 percent in the
third quarter to $2. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a 6 billion. This was led by growth in their compact
vehicle technologies, dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod onstruction technologies, industrial
technologies, and security technologi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin es. There was also an increase in
their parts, service, attachments, rent tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen l and used equipment sections. JLG Industries, McConnellsburg, PA had a re t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ord fourth quarter as
well. With a sales increase nationally of 33 percen ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t and 36 percent
internationally JLG showed a 34 percent increase in over y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ll revenue. Financial forecasts were upbeat and hopeful for this year as w . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ell.
Equipment prices will be higher this year due to higher material and
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip transportation costs, but the demand for renal equipment should not
change tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Travel Destination Spotlight
|